---
title: "Merit Medical Systems, Inc. (MMSI.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MMSI.US.md"
symbol: "MMSI.US"
name: "Merit Medical Systems, Inc."
industry: "Health Care Supplies"
datetime: "2026-05-21T10:21:46.412Z"
locales:
  - [en](https://longbridge.com/en/quote/MMSI.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MMSI.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MMSI.US.md)
---

# Merit Medical Systems, Inc. (MMSI.US)

## Company Overview

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems.

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Exchange | US Market |
| Website | [www.merit.com](https://www.merit.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:18.000Z

**Overall: B (0.34)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 5 / 45 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 11.10% |  |
| Net Profit YoY | 13.96% |  |
| P/B Ratio | 2.36 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3847141598.95 |  |
| Revenue | 1542432000.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 9.12% | B |
| Profit Margin | 9.03% | B |
| Gross Margin | 48.39% | B |
| Revenue YoY | 11.10% | B |
| Net Profit YoY | 13.96% | C |
| Total Assets YoY | 10.18% | B |
| Net Assets YoY | 13.88% | B |
| Cash Flow Margin | 213.50% | B |
| OCF YoY | 11.10% | B |
| Turnover | 0.59 | B |
| Gearing Ratio | 40.18% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Merit Medical Systems, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "11.10%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "13.96%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.36",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "3847141598.95",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "1542432000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "9.12%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "9.03%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "48.39%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "11.10%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "13.96%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "10.18%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "13.88%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "213.50%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "11.10%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.59",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "40.18%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 27.61 | 10/45 | 44.75 | 41.61 | 33.25 |
| PB | 2.36 | 25/45 | 3.58 | 3.32 | 2.70 |
| PS (TTM) | 2.49 | 26/45 | 3.72 | 3.44 | 2.82 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Essilor (ESLOY.US) | B | B | C | B | B | B |
| 02 | HOYA Corporation (HOCPY.US) | A | C | B | A | B | B |
| 03 | Align (ALGN.US) | B | C | B | B | C | B |
| 04 | Lantheus (LNTH.US) | A | C | B | C | C | B |
| 05 | Merit Medical (MMSI.US) | B | B | B | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-11T04:00:00.000Z

Total Analysts: **11**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 4 | 36% |
| Overweight | 5 | 45% |
| Hold | 2 | 18% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 64.49 |
| Highest Target | 122.00 |
| Lowest Target | 74.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/MMSI.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/MMSI.US/norm.md)
- [Related News](https://longbridge.com/en/quote/MMSI.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/MMSI.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**